The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study
A legfontosabb adatok
- Ki végzi
- The University of Hong Kong
- Hol
- Hongkong1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Fut, nem toboroz
- Fázis
- 4. fázis
- Résztvevők
- 600 fő, tervezett
- Kezdés
- 2025. okt. 1.
- Várható befejezés
- 2030. okt. 1.
- A vizsgálat típusa
- Beavatkozással járó, 4 csoport
- A vizsgált kezelések
- Live attenuated influenza vaccine
- Placebo nasal spray
- recombinant hemagglutinin influenza vaccine
- Placebo injection
- A regiszteradat frissítve
- 2026. május 15.
Ki vehet részt
- Életkor
- 22 év – 50 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 11 feltétel megnézéseKevesebb
Ki vehet részt
- Aged 22-50 years at enrolment
- A. Participated in the DRIVE I or DRIVE II studies (for DRIVE IIIa). OR B. Did not participate in the DRIVE I or DRIVE II study (for DRIVE IIIb) and has not received influenza vaccination in the prior two years
- Capable of providing informed consent
- Resident in Hong Kong in the coming 2 years
Ki nem vehet részt
- Currently taking medication for any condition that impairs immune system
- Individuals who report medical conditions not suitable to receive inactivated influenza vaccines, such as:; Severe allergic reaction (e.g., anaphylaxis) after previous dose of any influenza vaccine; or to a vaccine component; Moderate or severe acute illness with or without fever after any previous influenza vaccination; or; A history of Guillain-Barré syndrome (GBS) within 6 weeks of previous influenza vaccination
- Included in one of the priority groups to receive influenza vaccination in Hong Kong (priority groups include pregnant women, long-stay residents of institutions for persons with disability, persons with chronic medical problems (chronic cardiovascular, lung, metabolic or kidney diseases, obesity (body mass index 30 or above) and chronic neurological condition ), healthcare workers or persons working in poultry, pig farming or pig slaughtering industry)
- With diagnosed medical conditions related to their immune system
- Individuals who report medical conditions not suitable to receive live attenuated vaccines, such as:; having asthma; having close contact with severely immunosuppressed persons who require a protected environment; or; having immunosuppressive treatment (e.g. high-dose steroid, anti-cancer drugs and radiotherapy)
- Individuals who report medical conditions not suitable to receive intramuscular injection, such as; Bleeding disorders; Habitually taking anticoagulants (with the exception of antiplatelets such as aspirin)
- Individuals who have any medical conditions not suitable to receive inactivated or live attenuated influenza vaccines as determined by a clinician
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study will provide novel insight into the effects of repeat influenza vaccination with Flublok and FluMist on the strength and breadth of immune responses to influenza, the mechanisms underlying heterogeneity in vaccine response and vaccine failure, and biological factors that could explain variation in influenza vaccine effectiveness.
A vizsgálat 4 csoportja
- Arm 1: 4 x FluMistA vizsgált kezelés
FluMist four times annually
Kezelés: Live attenuated influenza vaccine és Placebo injection
- Arm 2: alternate FluMist and FlublokA vizsgált kezelés
Alternating FluMist and Flublok annually
Kezelés: Live attenuated influenza vaccine, Placebo nasal spray, recombinant hemagglutinin influenza vaccine és Placebo injection
- Arm 3: alternating Placebo and FlublokA vizsgált kezelés
Alternating Placebo and Flublok annually
Kezelés: Placebo nasal spray, recombinant hemagglutinin influenza vaccine és Placebo injection
- Arm 4: 4 x FlublokA vizsgált kezelés
Flublok four times annually
Kezelés: Placebo nasal spray és recombinant hemagglutinin influenza vaccine
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study - a Randomized Controlled Trial
- A regiszteradat frissítve
- 2026. május 15.